Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020

Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020–2022)

Published:2024-04 Issue:4 Volume:63 Page:107113
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Sader Helio S.^ORCID,Carvalhaes Cecilia G.^ORCID,Kimbrough John H.,Mendes Rodrigo E.,Castanheira Mariana

Funder

Pfizer Inc

Publisher

Elsevier BV

Reference32 articles.

1. Epidemiology of β-lactamase-producing pathogens;Bush;Clin Microbiol Rev,2020

2. Update of clinical application in ceftazidime-avibactam for multidrug-resistant gram-negative bacteria infections;Zhen;Infection,2022

3. Microbiology of meropenem-vaborbactam: a novel carbapenem beta-lactamase inhibitor combination for carbapenem-resistant Enterobacterales infections;Bhowmick;Infect Dis Ther,2020

4. OXA-48–like beta-lactamases: global epidemiology, treatment options, and development pipeline;Boyd;Antimicrob Agents Chemother,2022

5. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against Dual-Carbapenemase-Producing Enterobacterales;Infection and Drug Resistance;2024-09

2. Assessment of in vitro activity of ceftazidime/avibactam on carbapenemase‐producing Enterobacterales from Iran: An experimental study;Health Science Reports;2024-08

3. Treatment of multidrug-resistant Gram-negative bloodstream infections in critically ill patients: an update;Current Opinion in Critical Care;2024-07-08

4. Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia;Antibiotics;2024-05-14